D
endritic cells (DCs) exert their functions of immune sentinels in different anatomical places. The DCs that reside in the parenchyma of nonlymphoid tissues (NLT) are called interstitial DCs (int-DCs). These DCs shuttle tissue Ags to draining lymph nodes (LNs), where they are called migratory DCs (mig-DCs).
In mouse skin, DCs make up epidermal Langerhans cells (LCs) and three major subsets of dermal DCs: (Table I) . Although LCs and all dermal DC subsets constitutively migrate from skin to cutaneous LN (CLN), the CD103 + DCs stand out as the most potent subset for presenting keratinocytederived Ags to CD8 + T cells in the CLN (1) . This capacity is reminiscent of the high efficiency of lymphoid tissue (LT)-resident CD8a + DCs for cross-presentation (1) . CD103 + intDCs are also found in other anatomical places such as lung and gut. The development of CD103 + int-DCs and LTresident CD8a + DCs selectively depends on a common set of transcription factors (2, 3) . Hence, these mouse DC populations may belong to a unique category of CD8a + -type DCs (1) . CD8a + -type DCs exist in human and sheep, where their identification was based on their expression of a unique transcriptional fingerprint shared with mouse spleen CD8a + DCs (4, 5) and on their efficiency for Ag cross-presentation (5-9). We proposed a universal classification of DCs in five major subsets irrespective of tissues and species: monocytederived inflammatory DCs, LCs, plasmacytoid DCs, CD11b + -type DCs, and CD8a + -type DCs (1) . Yet, a discriminating marker identifying all CD8a + -type DCs across tissues remained to be determined. Moreover, the relationships between LT-resident CD8a + DCs and CD103 + mig-DCs or CD103 + int-DCs need to be confirmed. The chemokine receptor XCR1 is specifically expressed by CD8a + -type DCs in mouse spleen, human blood, and sheep lymph (4-7, 10). The function of XCR1 was first unveiled by the group of R. Kroczek (10), who showed that CD8 + T cell cross-priming depends on their ability to secrete the XCR1 ligand XCL1 in experimental models where either the OVA coupled to an anti-CD205 Ab or OVA-expressing allogeneic pre-B cells are administrated in vivo. XCR1 expression on CD8a + DCs was also found critical for the optimal induction of CD8 + T cell responses upon Listeria monocytogenes infection (6). We hypothesized that XCR1 may be the long sought marker defining all CD8a + -type DCs throughout the body. In this study, to investigate whether LT-resident CD8a + DCs and NLT-derived CD103 + DCs belong to the same DC subset and can be identified by a common specific marker across mouse tissues, we analyzed their expression of XCR1 and compared their gene expression profiles.
Materials and Methods

Mice
Xcr1
tm1Dgen mice (Xcr1-bGal) (6, 10) generated by Deltagen were bred in Centre d'Immunologie Marseille-Luminy animal care facilities. C57BL/6J mice were purchased from Charles River Laboratories (L'Arbresle, France). Studies were performed in accordance with institutional regulations governing animal care and use.
DC isolation and sorting strategy
DCs were isolated from various organs by a combination of enzymatic digestion, mechanical disruption, and gradient density enrichment (11). Sorting of CLN DCs was performed as described previously (12).
Abs and flow cytometry
Most Abs were purchased from eBioscience or BD Biosciences. Identification of mig-DCs was based on their specific pattern of expression of CD11c and MHC class II (Supplemental Fig. 1 ). CADM1 staining was performed with a chicken anti-SynCAM/TSLC1 Ab (clone 3.E.1) revealed with a goat antichicken IgG. XCR1 expression was detected using fluorescein di-b-D-galactopyranoside as a fluorogenic substrate for b-galactosidase (bGal) (6). In CLNs, XCR1 expression was also detected using recombinant mouse XCL1 covalently coupled to the red fluorescent protein mCherry (E. Fossum and B. Bogen, manuscript in preparation).
Microarray analyses and real-time PCR
Quality controls and normalization of a public expression data compendium of mouse DC subsets (ImmGen; Gene Expression Omnibus database GSE15907) were performed as described previously (6). The gene set enrichment analysis (GSEA) method is publicly available at http://www.broad. mit.edu/gsea (13) . To test whether GeneSets were enriched in pairwise comparisons between CD8a + LT-resident DCs or CD103 + NLT-derived DCs versus their CD11b + counterparts, nominal p values were calculated as well as false-discovery rate (q value), based on 1000 random permutations between GeneSets. Results were considered significant when p , 0.05 and q , 0.25 (13) . Real-time PCR experiments were performed as previously described (6) using the Hprt gene for normalization. Primer sequences are available upon request.
Results and Discussion
High level of XCR1 expression is selective for CD103 + int-DCs in skin and CD103
+ mig-DCs in CLNs
To investigate which DC subsets express XCR1 in skin and CLNs, we exploited a reporter mutant mouse model expressing b-galactosidase (bGal) in place of XCR1. In skin, the int-DC subsets encompass the epidermal LCs and the dermal subsets CD103 + DCs, CD103 2 DCs, CD11b + DCs, and CD11b 2 CD24 2 DCs (Fig. 1A , Table I ). In skin int-DCs, bGal activity was high in CD103 + DCs, low in CD103 (Fig. 1B, 1C ). In CLNs, only LT-resident CD8a + DCs and CD103 + mig-DCs expressed XCR1 (Fig.  1D, 1F ). The use of fluorescently labeled recombinant mouse XCL1 to stain CLN cells gave a strong and highly specific n.a., not applicable. signal on LT-resident CD8a + DCs and CD103 + mig-DCs from wild-type mice (Fig. 1E ). These data confirmed that the protein XCR1 is specifically expressed on LT-resident CD8a + DCs and CD103 + mig-DCs and validated the use of bGal activity as a faithful reporter of XCR1 expression. Therefore, in skin and CLNs, a high level of XCR1 expression is selective for CD8a + -type DCs.
XCR1 expression defines CD8a + -type DCs in visceral organs and their draining LNs
We next analyzed XCR1 expression on DCs residing in different tissues. As in skin and CLNs, three main populations were defined in the liver, lungs, and the small intestine: CD11b + DCs, CD103 + DCs, and CD103 2 DCs (Fig. 1A , Table I ). In these organs, XCR1 expression was high in CD103 + int-DCs, intermediate in CD103 2 int-DCs, and not detected in CD11b + int-DCs (Fig. 1H ), as observed in the skin. In the mig-DCs from mesenteric LNs (MLNs) and mediastinal LNs (MedLNs) draining, respectively, the intestine and the lung, XCR1 expression remained highest in the CD103
+ subset (Fig. 1I ). Despite the use of an inhibitor of endogeneous Gal activity, the CD103 + int-DCs in the intestine and the CD103 + mig-DCs in MedLN showed substantial levels of bGal activity in wild-type mice. However, a clear increase over that background signal could be detected in the corresponding subsets isolated from XCR1-bGal mice. Within LT-resident DCs, XCR1 expression remained confined to the CD8a + subset (Fig. 1J ). DCs not yet endowed with full cross-presentation potential. In these cultures, the acquisition of cross-presenting competence correlates with the expression of CD103 upon TLR or cytokine stimulation (14) . The acquisition of XCR1 in vivo might be exploited to follow the development of CD8a + -type DCs into full-fledged cross-presenting DCs in tissues.
LT-resident CD8a
+ DCs and NLT-derived CD103 + DCs share a common gene signature
To investigate the potential similarities between LT-resident CD8a + DCs and skin-derived CD103 + mig-DCs, which both specifically expressed XCR1, we analyzed the expression of several transcripts in DC subsets sorted from CLNs. We focused on Xcr1, Clec9a, Cadm1, Clnk, and Rab7b (5430435G22Rik), because these genes are expressed selectively in CD8a + -type DCs from mouse spleen, human blood, and sheep lymph (4, 5). CLEC9A, XCR1, and CADM1 contribute to confer their specific functions on spleen CD8a + DCs by promoting the cross-presentation of dead cell-associated Ags, the priming of CD8 + T cells, and the induction of IL-22 in CD8 + T cells (6, 10, 15, 16) . CLNK belongs to the SLP-76 family of adaptors critical for signal transduction by ITAMcoupled receptors. CLEC9A contains a hemi-ITAM motif and may signal through CLNK downstream of the Syk tyrosine kinase (15) . The small GTPase RAB7B expressed in endosomes may promote assembly of the machinery required for crosspresentation as suggested by the functions of its paralogs (17) . In CLNs, Xcr1, Clnk, Rab7b, Clec9a, and Cadm1 were expressed the highest in LT-resident CD8a + DCs and CD103 + mig-DCs ( Fig. 2A) . Tlr3 was expressed identically in all subsets of mig-DCs. As reported for spleen DC subsets (3), Batf3 + DC-specific genes ("CD8a DC" GeneSet encompassing 92 genes) and CD11b + DC-specific genes ("CD11b DC" GeneSet encompassing 75 genes) were examined for global enrichment of their expression in the ImmGen public microarray data when comparing CD8a + versus CD11b + LT-resident DCs from spleen, MLNs and CLNs, or CD103 + versus CD11b + int-DCs from lungs and liver, or CD103 + /TN versus CD11b + mig-DCs from CLNs and MLNs. The color of circles corresponds to the font color of the DC subset where the GeneSet is enriched. The circle surface area is proportional to the normalized enrichment score, which varies from 1 (no enrichment) to 5 (all genes of the GeneSet are expressed to higher levels in the same DC subset). The color intensity of circles is indicative of the false-discovery rate (FDR) statistical q value, which estimates the likelihood that the enrichment of the GeneSet represents a falsepositive finding. ND, not detectable; TN, triple-negative CD4 2 CD8a 2 CD11b 2 DCs.
expression was comparable in all CLN DC subsets ( Fig. 2A) . As expected, Itgae (CD103) was expressed selectively in CD103 + mig-DCs and in CD8a + LT-resident DCs. Therefore, the common expression of a specific gene signature, including Xcr1, Clec9a, Clnk, Rab7b, and Cadm1, by LTresident CD8a + DCs and skin-derived CD103 + mig-DCs confirms their belonging to the CD8a + -type DC subset. To determine whether XCR1 expression defined CD8a + -type DCs across tissues, we exploited public data from the Immunological Genome project, which spans DC subsets from many organs and their draining LNs (18) . Xcr1 transcript was expressed to high levels in all LT-resident CD8a + DCs in lung and liver CD103 + int-DCs as well as in MLN CD4 2 CD8 2 CD11b 2 triple-negative (TN) mig-DCs, as compared with CD11b + DCs (Fig. 2B) . Xcr1 transcripts were below the level of detection in CD103 + mig-DCs from CLNs, likely because of limitations in the sensitivity of the microarray technology. Consistently, Xcr1 expression levels assessed by real time-PCR were ∼100-fold lower in CLN CD103 + mig-DCs as compared with CLN-resident CD8a + DCs ( Fig.  2A) . A similar reduction was observed for Clec9a, Cadm1, Clnk, Itgae, and Rab7b ( Fig. 2A, 2B ). However, XCR1 and CADM1 were both still highly expressed in these cells at the protein level (Fig. 1D, 1E, 1G) . Therefore, the transcription of some genes may decrease upon maturation of CD103 + intDCs into mig-DCs, whereas expression of the corresponding proteins is maintained as a result of a sufficiently long half life.
To further verify the degree of similarity that exists between DC subsets expressing XCR1, we examined in the conventional subsets of DCs isolated from the same tissues the enrichment of gene expression signatures (GeneSets) specific of splenic CD8a + DCs or of splenic CD11b + DCs (Fig. 2C) . In all pairwise comparisons, we observed that the CD8a + DC-specific GeneSet was significantly enriched in LT-resident CD8a + DCs, CD103 + int-DCs, CD103 + mig-DCs, or TN mig-DCs (Fig.  2C) . Reciprocally, the CD11b + DC-specific GeneSet was significantly enriched in CD11b + DCs from all tissues. Nineteen genes from the CD8a + DC GeneSet were consistently expressed to higher levels in all CD8a + -type DCs as compared with their CD11b + -type DC counterparts (Supplemental Fig.  2 ). Some genes from the CD8a + DC GeneSet were not expressed on all CD8a + -type DCs. This observation pinpoints the necessity to assess the relationships between two cell subsets, based on their comparative expression of many markers. Although highly expressed by all CD8a + -type DCs, Clec9a and Cadm1 are also expressed by cell subsets other than CD8a + -type DCs in mice and humans, contrary to Xcr1 (6). This genome-wide expression profiling analysis confirmed the existence of CD8a + -type DCs characterized by XCR1 expression across all examined tissues in mice.
In conclusion, we identified for the first time to our knowledge a robust and specific marker defining mouse CD8a + -type DCs in all the LT and NLT examined. This marker, the chemokine receptor XCR1, is also specifically expressed by human blood BDCA3 + DCs and sheep lymph CD26 + DCs and conserved during evolution (5, 6). Thus, the community of the researchers working on DCs may consider using the term "XCR1 + DCs" to designate CD8a + -type DCs in a consistent manner across all mammalian species and tissues to further implement the definition of a universal nomenclature for mouse and human DC subsets (19) . 
